divis
adjust ep dec yoy vs essenti in-lin figur
ep estim remain record help
approxim tax rate vs oper incom fiscal year model
factor somewhat conserv outlook ep estim
project
leader infect prevent equip report dec adjust ep vs
year earlier compar report year-over-year period yoy unless otherwis indic essenti in-
line figur oper incom match project ep benefit
revenu increas million price contribut bp constant currenc organ growth
 revenu corpor total fell million revenu
million revenu increas million
adjust gross profit rose million increas bp sale due price fx
divestitur partial off-set higher labor cost tariff impact adjust sg expens equal
revenu vs bp neg impact higher-than-anticip healthcar benefit
claim activ expens equal revenu vs adjust oper profit
million revenu vs tax rate around vs favor discret
item adjust net incom increas million net margin rose sale vs
healthcar product sale infect prevent procedur solut
healthcar provid world-wide includ capit equip washer steam ga steril surgic
tabl light clean chemistri relat mainten instal servic well consum
organ constant currenc basi million backlog jump yoy
pleas see import disclosur end report
million rose sequenti capit equip rose consum increas impact
divestitur consum busi impact anniversari servic
increas approxim busi replac remain project
consum track procedur volum equip align building/rehab project
oper profit increas million group margin vs due
time oper expens partial off-set increas volum favor fx
healthcar specialti servic rang specialti servic healthcar provid includ
hospit steril servic instrument scope repair linen manag organ
oper profit rose million vs million group margin vs
due leverag invest made last sever quarter although invest
outsourc instrument reprocess continu impact segment result depend level
invest particular quarter smaller outsourc project work gener return
month well larger project involv build new facil staf etc may take
year reach optim margin start-up natur longer term project ad lumpi
appli steril technolog ast contract steril laboratori servic medic
devic manufactur pharmaceut custom other million sale rose
organ increas volum segment core medic devic custom group oper profit
million group oper margin revenu vs due revenu
growth inflationari price includ busi contract steri
offset higher labor cost increas product
life scienc ls consist capit equip consum product washer steril
etc equip mainten specialti servic pharmaceut manufactur research
institut lumpi busi due variabl construct deliveri schedul rose organ
million capit equip declin given tough comp jump year ago
consum servic ls backlog decreas million ls longer lead time
ls oper profit rose million group margin vs due volum
favor mix consum highest margin follow servic capit equip
balanc sheet decemb includ cash equival million equiti billion
debt billion provid debt-to-tot capit ratio vs slightli
ebitda comfort rang
flow oper cfo quarter million vs million year earlier total
million first nine month vs million note activ pipelin
acquisit primarili tuck-in project free cash flow million
million previous due million cost reloc headquart ireland million restructur
cost increas inventori given backlog strength share repurchas quarter
million remain board author share repurchas use off-set option dilut
sale earn outlook
move headquart time uk ireland end march
brexit risk loss signific benefit headquart countri domicil outsid eu
expens relat move amount million exclud adjust ep
hospit capit spend reportedli continu stabl posit two-third busi
routin replac capit spend visibl month remain one-third
construction/expans project month visibl hospit non-hospit build
pleas see import disclosur end report
divis wellington shield co llc
ambulatori surgeri center micro hospit
result current quarter benefit strength given record backlog solid capit
equip shipment expect although move even-out yearli result rather histor
strong improv manufactur util could hamper growth quarter compar year
earlier ep estim vs last year previous revenu
million
ep estim remain vs record compani reiter guidanc
revenu billion continu target revenu growth year
constant currenc despit million headwind divestitur million fx base
year-end rate northwel partnership northwel hospit group account surgic
procedur new york project expect gener approxim million
revenu full-year run rate million futur year model oper margin
record vs gross free cash flow estim per
share respect assum net incom million million exclud intang
amort around million alreadi deduct adjust net incom figur capital-expenditure
million dividend million
factor slightli conserv forecast ep estim revenu
billion assum continu solid hospit spend plan
product ration manufactur consolid expect save million next
two year primari benefit oper margin model bp
revenu long-term target organ growth double-digit ep growth
share trade forward ep estim project
year growth rate rate hold due valuat remain posit fundament
includ satisfactori hospit spend potenti outsourc margin improv initi
rel immun polit pressur healthcar compani given histor
consist result balanc sheet/cash flow strength would look upgrad rate gradual
accumul around project growth rate vs typic approxim sell
ev-to-ebitda ratio project ebitda million project
ebitda million share trade price-to-earnings ratio base upon trail report ep
current
global hospit spend environ key variabl deriv approxim revenu
outsid subject compani increas geograph risk well vagari foreign currenc
fluctuat medic technolog compani product obsolesc and/or increas competit
relev risk regulatori issu continu import mani compani product process
subject fda approv and/or inspect
pleas see import disclosur end report
divis wellington shield co llc
march fiscal year-end
mm ex per share
good sold
good sold
pleas see import disclosur end report
